Control Bionics Limited (ASX:CBL)
0.0600
0.00 (0.00%)
Sep 17, 2026, 2:55 PM AEST
Control Bionics Financials Overview
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Revenue Revenue Growth | 4.77 | 4.77 | 6.14 | 5.35 | 5.64 | 4.5 |
Revenue Growth | -21.45% | -22.43% | 14.84% | -5.17% | 25.33% | 10.11% |
Gross Profit Gross Profit Growth | 2.36 | 2.36 | 3.63 | 3.9 | 3.71 | 2.51 |
Operating Income Operating Income Growth | -6.66 | -6.66 | -5.72 | -5.78 | -5.24 | -6.18 |
Net Income Net Income Growth | -7.27 | -7.27 | -6.11 | -5.91 | -5.63 | -6.1 |
Earnings Per Share EPS Growth | -0.02 | -0.02 | -0.02 | -0.04 | -0.06 | -0.07 |
EPS Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 |
North America (US) North America (US) Growth | 4.37 | 4.37 | 5.68 | 4.96 | 4.89 |
Japan and other markets Japan and other markets Growth | 0.08 | 0.08 | 0.13 | 0.06 | 0.01 |
Corporate Corporate Growth | 0.55 | 0.55 | 0.56 | -0.71 | -0.43 |
Australia Australia Growth | 0.85 | 0.85 | 1.26 | 1.09 | 1.23 |
R&D R&D Growth | 0.63 | 0.63 | 0.72 | 0.95 | 0.41 |
Elimination Elimination Growth | -1.08 | -1.08 | -1.31 | - | - |
Total Total Growth | 5.4 | 5.4 | 7.04 | 6.36 | 6.11 |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Cash & Investments Cash & Investments Growth | 2.15 | 2.15 | 0.67 | 1.06 | 0.99 | 5.27 |
Total Debt Total Debt Growth | 0.62 | 0.62 | 0.44 | 0.96 | 0.13 | 0.28 |
Net Cash (Debt) Net Cash Growth | 1.54 | 1.54 | 0.24 | 0.1 | 0.86 | 4.99 |
Net Cash Growth | -45.50% | 547.34% | 144.73% | -88.77% | -82.69% | -59.56% |
Net Cash Per Share Net Cash Per Share Growth | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.06 |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Operating Cash Flow Operating Cash Flow Growth | -5.75 | -5.75 | -4.27 | -4.91 | -4.54 | -6.89 |
Capital Expenditures CapEx Growth | -0.01 | -0.01 | -0.3 | -0.4 | -0.42 | -0.15 |
Free Cash Flow Free Cash Flow Growth | -5.76 | -5.76 | -4.57 | -5.31 | -4.96 | -7.03 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Gross Margin | 49.41% | 49.41% | 59.05% | 72.82% | 65.78% | 55.68% |
Operating Margin | -139.79% | -139.79% | -93.16% | -108.02% | -92.78% | -137.19% |
Pretax Margin | -152.42% | -152.42% | -99.41% | -110.52% | -99.80% | -135.53% |
Profit Margin | -152.42% | -152.42% | -99.41% | -110.52% | -99.80% | -135.53% |
FCF Margin | -120.81% | -120.81% | -74.40% | -99.24% | -87.84% | -156.26% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 17, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
PS Ratio | 6.84 | 6.40 | 1.44 | 1.94 | 1.40 | 4.34 |